BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Iughetti L, Bigi E, Venturelli D. Novel insights in the management of sickle cell disease in childhood. World J Clin Pediatr 2016; 5(1): 25-34 [PMID: 26862499 DOI: 10.5409/wjcp.v5.i1.25]
URL: https://www.wjgnet.com/2219-2808/full/v5/i1/25.htm
Number Citing Articles
1
Larissa C. Rocha, Magda O. S. Carvalho, Valma M. L. Nascimento, Milena S. dos Santos, Tânia F. Barros, Elisângela V. Adorno, Joice N. Reis, Caroline C. da Guarda, Rayra P. Santiago, Marilda de Souza Gonçalves. Nasopharyngeal and Oropharyngeal Colonization by Staphylococcus aureus and Streptococcus pneumoniae and Prognostic Markers in Children with Sickle Cell Disease from the Northeast of BrazilFrontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.00217
2
Elaine Cristina Rodrigues Gesteira, Regina Szylit, Maiara Rodrigues dos Santos, Carolliny Rossi de FariaIchikawa, Patricia Peres de Oliveira, Edilene Aparecida Araújo Silveira. Family management ofchildren who experience sickle cell disease: a qualitative studyRevista Brasileira de Enfermagem 2020; 73( suppl 4) doi: 10.1590/0034-7167-2019-0521
3
Emmanuel Ifeanyi Obeagu, Getrude Uzoma Obeagu. Management of diabetes mellitus patients with sickle cell anemia: Challenges and therapeutic approachesMedicine 2024; 103(17): e37941 doi: 10.1097/MD.0000000000037941
4
Milena Magalhães Aleluia, Caroline Conceição da Guarda, Rayra Pereira Santiago, Teresa Cristina Cardoso Fonseca, Fábia Idalina Neves, Regiana Quinto de Souza, Larissa Alves Farias, Felipe Araújo Pimenta, Luciana Magalhães Fiuza, Thassila Nogueira Pitanga, Júnia Raquel Dutra Ferreira, Elisângela Vitória Adorno, Bruno Antônio Veloso Cerqueira, Marilda de Souza Gonçalves. Association of classical markers and establishment of the dyslipidemic sub-phenotype of sickle cell anemiaLipids in Health and Disease 2017; 16(1) doi: 10.1186/s12944-017-0454-1
5
Talal Qadah. The Effect of Fetal Hemoglobin on RBC Parameters among Sickle Cell Anemia Patients: A Cross Sectional Study from Makkah City; Western Saudi ArabiaHematology & Transfusion International Journal 2016; 3(1) doi: 10.15406/htij.2016.03.00059
6
Nathalia Noyma Sampaio Magalhães, Lucas Barra Mathiasi, Daniela de Oliveira Werneck Rodrigues. Importance of neonatal screening: A case study of sickle cell disease and cystic fibrosis coexistenceWorld Journal of Clinical Pediatrics 2025; 14(1): 97537 doi: 10.5409/wjcp.v14.i1.97537
7
Bertin Tshimanga Kadima, Jean Lambert Gini‐Ehungu, Fiston Ikwa Ndol Mbutiwi, John Tunda Bahati, Michel Ntetani Aloni. Validity of simple clinical and biological parameters as screening tool for sickle cell anemia for referral to tertiary center in highly resource constraintsJournal of Clinical Laboratory Analysis 2017; 31(6) doi: 10.1002/jcla.22145
8
Stephen Otieno Gwer, Kennedy Odoyo Onyango. Prevalence and incidence of congenital anomalies amongst babies born to women with sickle cell disease and exposed to hydroxyurea during pregnancy: a systematic review protocolJBI Database of Systematic Reviews and Implementation Reports 2018; 16(5): 1135 doi: 10.11124/JBISRIR-2017-003548
9
Liliane K. Siransy, Romuald S. Dasse, Honoré Adou, Patricia Kouacou, Sidonie Kouamenan, Yassongui Sekongo, Richard Yeboah, Charlene Memel, Aniella Assi-Sahoin, Salimata Y. Moussa, Doris Oura, Jocelyne Seri. Are IL-1 family cytokines important in management of sickle cell disease in Sub-Saharan Africa patients?Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.954054
10
Sylvia Thurn, Katharina Kleinschmidt, Irena Kovacic, Christina Wendl, Ralf A. Linker, Selim Corbacioglu, Felix Schlachetzki. Transcranial Doppler sonography and the effect of haematopoietic stem cell transplantation in sickle cell diseaseNeurological Research and Practice 2022; 4(1) doi: 10.1186/s42466-022-00175-y
11
Faramarz Naeim, P. Nagesh Rao, Sophie X. Song. Atlas of Hematopathology with 100 Case Studies2024; : 83 doi: 10.1016/B978-0-443-18838-1.00005-0
12
Clark Brown, Modupe Idowu, Richard Drachtman, Anne Beaubrun, Irene Agodoa, Andy Nguyen, Kelly Lipman, Olga Moshkovich, Ryan Murphy, M. Alex Bellenger, Wally Smith, Krzysztof Siemianowicz. Patient‐Reported Experiences in Voxelotor‐Treated Children and Adults with Sickle Cell Disease: A Semistructured Interview StudyBioMed Research International 2023; 2023(1) doi: 10.1155/2023/7533111
13
Sawsan M. Moeen, Ahmad F. Thabet, Hosam A. Hasan, Medhat A. Saleh. Lower Transcranial Doppler Flow Velocities in Sickle Cell Anemia Patients on Hydroxyurea: Myth or FactIndian Journal of Hematology and Blood Transfusion 2018; 34(1): 97 doi: 10.1007/s12288-017-0814-z
14
Hayfaa Mohammed Mones, Meaad Kadhum Hassan, Bahaa Abd Al Hussein Ahmed. Health-Related Quality of Life of Adolescents with Sickle Cell Disease on HydroxyureaJournal of Applied Hematology 2022; 13(1): 13 doi: 10.4103/joah.joah_7_21
15
V. Mandese, E. Bigi, P. Bruzzi, G. Palazzi, B. Predieri, L. Lucaccioni, M. Cellini, L. Iughetti. Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: an Italian cohort studyBMC Pediatrics 2019; 19(1) doi: 10.1186/s12887-019-1423-9
16
Fellipe Bondança Pereira, Glaura César Pedroso, Rosa Miranda Resegue, Marcos Vinicius Vieira Ribeiro, Mary Hokazono, Josefina Aparecida Pellegrini Braga. BEHAVIORAL CHARACTERISTICS OF CHILDREN WITH SICKLE CELL DISEASERevista Paulista de Pediatria 2021; 39 doi: 10.1590/1984-0462/2021/39/2019341
17
Wilfrid Mbombo Dibue, Alphonse Mosolo Nganzele, Freddy MBUYI wa Mukishi, Berthe Barhayiga Nsimire, Jean Robert MAKULO Ali Risasi, Jean Joseph Echarri, Jean René Ngiyulu, Léon Tshilolo Muepu. Morbidité et mortalité en anesthésie pour arthroplastie totale de la hanche sur terrain de drépanocytose dans un pays à faible revenu : cas du centre hospitalier MonkoleAnesthésie & Réanimation 2024; 10(5-6): 486 doi: 10.1016/j.anrea.2024.10.008
18
Sarah L. Reeves, Hannah K. Peng, Jeffrey J. Wing, Lindsay W. Cogan, Alka Goel, David Anders, Nancy S. Green, Lynda D. Lisabeth, Kevin J. Dombkowski. Changes in Hydroxyurea Use Among Youths Enrolled in Medicaid With Sickle Cell Anemia After 2014 Revision of Clinical GuidelinesJAMA Network Open 2023; 6(3): e234584 doi: 10.1001/jamanetworkopen.2023.4584
19
Narjeet Khurmi, Andrew Gorlin, Lopa Misra. Perioperative considerations for patients with sickle cell disease: a narrative reviewCanadian Journal of Anesthesia/Journal canadien d'anesthésie 2017; 64(8): 860 doi: 10.1007/s12630-017-0883-3
20
Faramarz Naeim, P. Nagesh Rao, Sophie X. Song, Ryan T. Phan. Atlas of Hematopathology2008; : 885 doi: 10.1016/B978-0-12-809843-1.00064-4
21
Sarah L. Reeves, Hannah K. Jary, Jennifer P. Gondhi, Jean L. Raphael, Lynda D. Lisabeth, Kevin J. Dombkowski. Hydroxyurea Initiation Among Children With Sickle Cell AnemiaClinical Pediatrics 2019; 58(13): 1394 doi: 10.1177/0009922819850476
22
Aimé Lukusa Kazadi, René Makuala Ngiyulu, Jean Lambert Gini-Ehungu, Jean Marie Mbuyi-Muamba, Michel Ntetani Aloni. Factors Associated with Growth Retardation in Children Suffering from Sickle Cell Anemia: First Report from Central AfricaAnemia 2017; 2017: 1 doi: 10.1155/2017/7916348
23
Sherif M. Badawy. Fetal hemoglobin level and nutritional status in patients with sickle cell diseaseNutrition Journal 2015; 15(1) doi: 10.1186/s12937-016-0181-x
24
Sahar Alrayyes, Anne-Ashley Compton, Nadia Kawar. Oral health considerations for pediatric patients with sickle cell diseaseDisease-a-Month 2018; 64(6): 302 doi: 10.1016/j.disamonth.2017.12.006
25
Baba Psalm Duniya Inusa, Wale Atoyebi, Abdul Aziz Hassan, Tushar Idhate, Livingstone Dogara, Ifeoma Ijei, Yewen Qin, Kofi Anie, Juliana Olufunke Lawson, Lewis Hsu. Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settingsF1000Research 2018; 7: 1407 doi: 10.12688/f1000research.14589.1